Skip to content
July 02, 2022

Equity.Guru

Investment information for the new generation

August 16, 2021

Sixth Wave Innovations (SIXW.C) announced that they signed a contract with Rio2 which will see tests continue with Sixth Wave’s patented IXOS purification polymer at Rio2’s Fenix Gold Project in…
Valeo Pharma (VPH.C) announced today that it has completed implementation of its new corporate structure and launched full commercial activities in support of Enerzair Breezhaler triple therapy and Atectura…
Cryptocurrencies had a stellar weekend. Major technical levels were broken, and this week will determine whether we just see pullbacks, or if the larger intact uptrend remains. Many of…
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8…
Wednesday night marked the last time the sun will set at or after 8pm until May 9th, 2022.  And if you can believe it, that is probably the best…
NanoVibronix (NAOV.Q) announced today that it intends to enter the Over-the-Counter (OTC) pain relief market with the introduction of PainShield RELIEF™, a non-prescription ultrasound therapy device that delivers fast…
Filament Health (FH.NE) is developing a pipeline of natural psychedelics products to treat mental health problems like depression and anxiety. August 3, 2021, FH received a patent for the…
In this episode, we take a look at a company that’s on a mission to get safe, natural psychedelics into the hands of everyone who needs them, as soon…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Researching Filament Health (FH.NE) taught me a lot about the psychedelic space and shroom stocks. As someone who is big on eating clean and organic food, it came to…